---
title: "Medication Burden, Drug Interactions and Acute Kidney Injury in Critically Ill Cancer Patients"
id: "pubmed-43006428"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-43006428"
content_type: "clinical_feed_article"
specialty: "Critical Care"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/43006428/"
doi: "10.1177/10781552261506996"
published_at: "2026-11-10T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Medication Burden, Drug Interactions and Acute Kidney Injury in Critically Ill Cancer Patients
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-43006428
- **Specialty:** [Critical Care](https://medichelpline.com/clinical-feed/critical-care.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/43006428/)
- **DOI:** [10.1177/10781552261506996](https://doi.org/10.1177%2F10781552261506996)
- **Published At:** 2026-11-10T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- Retrospective observational cohort of critically ill adults with malignancy who received anticancer therapy within 30 days before or during ICU stay; study period reported as August 2025 to September 2026. - AKI defined and staged using **KDIGO** criteria; 210 patients included and 86 (41.0%) developed AKI during their ICU admission. - Investigators quantified medication burden as total number of distinct drugs and number of nephrotoxic drugs; potential drug–drug interactions (pDDIs) were screened using a standard interaction database. - The cohort with AKI had higher median drug counts (11 vs 8) and more pDDIs (6 vs 3); both differences were reported as p < 0.001. - Multivariable logistic regression identified independent predictors of AKI: ≥10 distinct drugs (aOR 2.62; 95% CI 1.32–5.18), at least one nephrotoxicity-related pDDI (aOR 2.87; 95% CI 1.43–5.76), higher **APACHE II** score (aOR 1.09 per point), pre-existing chronic kidney disease, sepsis, and exposure to **cisplatin**. - In-hospital mortality was higher among patients with AKI (39.5% vs 21.8%; p = 0.007). - The authors recommended routine pharmacist-led medication review and renal-focused interaction screening as potential strategies to reduce preventable kidney injury in this population. - The source did not report additional methodological details such as exact interaction database name, dosing regimens, or granular timing of AKI relative to specific drug exposures beyond the 30-day anticancer therapy window.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/43006428/#article-details) ### NIH Websites Are Changing * [Get the Latest Updates and FAQs on the transition](https://www.nih.gov/web-modernization) * Per [Executive Order 14434](https://www.whitehouse.gov/presidential-actions/2026/09/inaugurating-the-era-of-super-intelligence/), federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition. ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43006428%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/43006428/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/43006428/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/43006428/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/43006428/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/43006428/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/43006428/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43006428%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43006428%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/43006428/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43006428/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43006428/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/43006428/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43006428/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/43006428/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/43006428/#abstract) Title & authors Abstract J Oncol Pharm Pract Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22J+Oncol+Pharm+Pract%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J+Oncol+Pharm+Pract%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43006428/) . 2026 Nov 10:10781552261506996. doi: 10.1177/10781552261506996. Online ahead of print. # Association of medication burden and potential drug-drug interactions with acute kidney injury among critically ill patients receiving anticancer therapy at a tertiary care centre [Laya Mahadevan](https://pubmed.ncbi.nlm.nih.gov/?term=Mahadevan+L&cauthor_id=43006428)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43006428/#full-view-affiliation-1 "Department of Critical Care Medicine, Saveetha Medical College and Hospitals, SIMATS, Chennai, Tamil Nadu, India."), [Induja Saravanan](https://pubmed.ncbi.nlm.nih.gov/?term=Saravanan+I&cauthor_id=43006428)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43006428/#full-view-affiliation-1 "Department of Critical Care Medicine, Saveetha Medical College and Hospitals, SIMATS, Chennai, Tamil Nadu, India."), [Jaideep P](https://pubmed.ncbi.nlm.nih.gov/?term=P+J&cauthor_id=43006428)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43006428/#full-view-affiliation-2 "Department of Anaesthesia and Critical Care, Sarojini Naidu Medical College, Agra, India.") Affiliations Expand ### Affiliations * 1 Department of Critical Care Medicine, Saveetha Medical College and Hospitals, SIMATS, Chennai, Tamil Nadu, India. * 2 Department of Anaesthesia and Critical Care, Sarojini Naidu Medical College, Agra, India. * PMID: **43006428** * DOI: [ 10.1177/10781552261506996 ](https://doi.org/10.1177/10781552261506996) Item in Clipboard # Association of medication burden and potential drug-drug interactions with acute kidney injury among critically ill patients receiving anticancer therapy at a tertiary care centre Laya Mahadevan et al. J Oncol Pharm Pract. 2026. Show details Display options Display options Format Abstract PubMed PMID J Oncol Pharm Pract Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22J+Oncol+Pharm+Pract%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J+Oncol+Pharm+Pract%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43006428/) . 2026 Nov 10:10781552261506996. doi: 10.1177/10781552261506996. Online ahead of print. ### Authors [Laya Mahadevan](https://pubmed.ncbi.nlm.nih.gov/?term=Mahadevan+L&cauthor_id=43006428)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43006428/#short-view-affiliation-1 "Department of Critical Care Medicine, Saveetha Medical College and Hospitals, SIMATS, Chennai, Tamil Nadu, India."), [Induja Saravanan](https://pubmed.ncbi.nlm.nih.gov/?term=Saravanan+I&cauthor_id=43006428)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43006428/#short-view-affiliation-1 "Department of Critical Care Medicine, Saveetha Medical College and Hospitals, SIMATS, Chennai, Tamil Nadu, India."), [Jaideep P](https://pubmed.ncbi.nlm.nih.gov/?term=P+J&cauthor_id=43006428)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43006428/#short-view-affiliation-2 "Department of Anaesthesia and Critical Care, Sarojini Naidu Medical College, Agra, India.") ### Affiliations * 1 Department of Critical Care Medicine, Saveetha Medical College and Hospitals, SIMATS, Chennai, Tamil Nadu, India. * 2 Department of Anaesthesia and Critical Care, Sarojini Naidu Medical College, Agra, India. * PMID: **43006428** * DOI: [ 10.1177/10781552261506996 ](https://doi.org/10.1177/10781552261506996) Item in Clipboard Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract BackgroundCritically ill patients with cancer are exposed to many drugs, including anticancer agents, antimicrobials and supportive medications, which increases the risk of nephrotoxicity and potential drug-drug interactions (pDDIs). The contribution of medication burden and pDDIs to acute kidney injury (AKI) in this population is not well characterised.ObjectiveTo assess the association of medication burden and pDDIs with AKI among critically ill patients receiving anticancer therapy.MethodsThis retrospective observational study was conducted in the intensive care units (ICUs) of a tertiary care centre from August 2025 to September 2026. Adults with malignancy who received anticancer therapy within 30 days before or during ICU stay were included. AKI was defined and staged by KDIGO criteria. Medication burden (total drugs and nephrotoxic drugs) and pDDIs (screened using a standard interaction database) were recorded. Multivariable logistic regression was used to identify independent predictors of AKI.ResultsOf 210 patients, 86 (41.0%) developed AKI. Patients with AKI had a higher median number of drugs (11 vs 8, p < 0.001) and pDDIs (6 vs 3, p < 0.001). Independent predictors of AKI were ≥10 distinct drugs (aOR 2.62; 95% CI 1.32-5.18), at least one nephrotoxicity-related pDDI (aOR 2.87; 95% CI 1.43-5.76), APACHE II score (aOR 1.09 per point), pre-existing CKD, sepsis, and cisplatin exposure. In-hospital mortality was higher with AKI (39.5% vs 21.8%, p = 0.007).ConclusionHigh medication burden and nephrotoxicity-related pDDIs were independently associated with AKI in critically ill cancer patients. Routine pharmacist-led medication review and renal-focused interaction screening may help reduce preventable kidney injury. **Keywords:** Acute kidney injury; anticancer therapy; clinical pharmacy; critical illness; drug–drug interactions; polypharmacy. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM **Send To** * [Clipboard](https://pubmed.ncbi.nlm.nih.gov/43006428/) * [Email](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43006428%2F%23open-email-panel) * [Save](https://pubmed.ncbi.nlm.nih.gov/43006428/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43006428%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43006428%2F%23open-collections-panel) * [Citation Manager](https://pubmed.ncbi.nlm.nih.gov/43006428/) [x] NCBI Literature Resources [MeSH](https://www.ncbi.nlm.nih.gov/mesh/) [PMC](https://www.ncbi.nlm.nih.gov/pmc/) [Bookshelf](https://www.ncbi.nlm.nih.gov/books) [Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited. Follow NCBI [ Twitter ](https://twitter.com/ncbi) [ Facebook ](https://www.facebook.com/ncbi.nlm) [ LinkedIn ](https://www.linkedin.com/company/ncbinlm) [ GitHub ](https://github.com/ncbi) [ ](https://ncbiinsights.ncbi.nlm.nih.gov/) [Connect with NLM](https://www.nlm.nih.gov/socialmedia/index.html) * [ Twitter ](https://twitter.com/NLM_NIH) * [ SM-Facebook ](https://www.facebook.com/nationallibraryofmedicine) * [ SM-Youtube ](https://www.youtube.com/user/NLMNIH) National Library of Medicine [8600 Rockville Pike Bethesda, MD 20894](https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323) [Web Policies](https://www.nlm.nih.gov/web_policies.html) [FOIA](https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office) [HHS Vulnerability Disclosure](https://www.hhs.gov/vulnerability-disclosure-policy/index.html) [Help](https://support.nlm.nih.gov/?pagename=pubmed%3Apubmed%3Aabstract%3ANONE) [Accessibility](https://www.nlm.nih.gov/accessibility.html) [Careers](https://www.nlm.nih.gov/careers/careers.html) * [NLM](https://www.nlm.nih.gov/) * [NIH](https://www.nih.gov/) * [HHS](https://www.hhs.gov/) * [USA.gov](https://www.usa.gov/)
## Related Clinical Research

- [PDK4 and Acute Kidney Injury: Metabolic Control of AKI and the AKI‑to‑CKD Transition](https://medichelpline.com/clinical-feed/pubmed-43059392.md) (DOI: 10.3892/mmr.2026.14075)
- [Bariatric Surgery Perioperative Risk Varies by Chronic Kidney Disease Stage, NIS 2016–2022](https://medichelpline.com/clinical-feed/pubmed-42983176.md) (DOI: 10.1007/s11695-026-09003-7)
- [IL-33 and kidney disease: article metadata and reporting gaps in Frontiers in Immunology](https://medichelpline.com/clinical-feed/frontiers-in-immunology-13-beyond-the-alarm-unveiling-the-multifaceted-role-of-il-33-in-kidney-disease.md)
- [Acquired immune-mediated TTP after ivonescimab chemoimmunotherapy with cholestatic liver injury an](https://medichelpline.com/clinical-feed/frontiers-in-immunology-18-acquired-immune-mediated-thrombotic-thrombocytopenic-purpura-with-severe.md)
- [KDOQI guideline adherence and reporting plausibility in Bangladeshi hemodialysis patients](https://medichelpline.com/clinical-feed/plos-one-3-dietary-intake-patterns-and-kdoqi-guideline-compliance-among-hemodialysis.md)

## Navigation
- [← Back to Critical Care Feed](https://medichelpline.com/clinical-feed/critical-care.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.